DR RECKEWEG R30
⚠️ High Risk
FEI: 3027326427 • Haryana • INDIA
FEI Number
3027326427
Location
Haryana
Country
INDIAAddress
5th Fl Tower B Presiden, , Haryana, , India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/7/2023 | 66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/7/2023 | 66YCY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 66HDA99SWEETENER N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 61NDL99ANTI-DEPRESSANT N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 61SDL99ANTI-ECZEMATIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 64RDL99HORMONE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 63PDL99CHOLINESTERASE REACTIVATOR N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 61JDL99ANTI-CHOLESTEREMIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 64UDL06FINASTERIDE (INHIBITOR (DECARBOXYLASE)) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 61HDL99ANTI-BACTERIAL, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 62GDL99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 61EDL99ANTI-ASTHMATIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 65ZDL01VARENICLINE TARTRATE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 62GDL99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/16/2023 | 60LDJ99ANALGESIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is DR RECKEWEG R30's FDA import refusal history?
DR RECKEWEG R30 (FEI: 3027326427) has 15 FDA import refusal record(s) in our database, spanning from 6/16/2023 to 8/7/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. DR RECKEWEG R30's FEI number is 3027326427.
What types of violations has DR RECKEWEG R30 received?
DR RECKEWEG R30 has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about DR RECKEWEG R30 come from?
All FDA import refusal data for DR RECKEWEG R30 is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.